Home
About
FAQ
History (4)
A randomized pilot study comparing graft-first to fistula-first strategies in older patients with incident end-stage kidney disease: Clinical rationale and study design.
Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations.
PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes.
Zimbabwe
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (98)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
Kyle M. Fargen MD, MPH, FAANS
Wake Forest School of Medicine
Why?
J. M. Cline DVM, PhD
Wake Forest School of Medicine
Why?
Michelle M. Mielke PhD
Wake Forest School of Medicine
Why?
Michael Y. Chen MD
Wake Forest School of Medicine
Why?
Cheryl D. Bushnell MD
Wake Forest School of Medicine
Why?
Christopher T. Whitlow MD, PhD, MHA
Wake Forest School of Medicine
Why?
Timothy M. Hughes PhD
Wake Forest School of Medicine
Why?
Elsayed Z. Soliman MD, MS
Wake Forest School of Medicine
Why?
Patrick S. Reynolds MD
Wake Forest School of Medicine
Why?
Jeff D. Williamson MD, MHS
Wake Forest School of Medicine
Why?
Christina E. Hugenschmidt PhD
Wake Forest School of Medicine
Why?
Charles H. Tegeler MD
Wake Forest School of Medicine
Why?
Suzanne Craft PhD
Wake Forest School of Medicine
Why?
Stacey Q. Wolfe MD
Wake Forest School of Medicine
Why?
David M. Reboussin PhD
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 7
Next
Prev
Search Criteria
Cerebrovascular Disorders
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions